HIV drug's Medicare costs under negotiation

HIV Drug’s Medicare Costs Under Negotiation

The Advocate reports that the federal government is negotiating lower Medicare prices for a popular once-daily pill that treats HIV and prevents infection. Read more at the Advocate

HIV drug's Medicare costs under negotiation

The federal government is negotiating lower Medicare prices for a popular once-daily pill that treats HIV and prevents infection.The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV exposure — known as a post-exposure prophylaxis — to prevent HIV infection as well as a treatment for those living with …